Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (181-190 of 409) with videos related to

Pageof 41
Sort By:
Wellcome Open Research|October 9, 2019
Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patientsRichard Kwizera, Fiona V Cresswell, Gerald Mugumya, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
BMC Infectious Diseases|June 28, 2019
Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort studyCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2012
Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohortJosé E Vidal, Juliana Gerhardt, Erique J Peixoto de Miranda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2018
Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in TanzaniaDiana Faini, Aneth Vedastus Kalinjuma, Andrew Katende, et al.
Medical Mycology|May 15, 2020
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agendaPeter G Pappas, David R Boulware, Dimitrios P Kontoyiannis, et al.
The Journal of Antimicrobial Chemotherapy|September 14, 2022
A post-mortem analysis of tenofovir, lamivudine, efavirenz and fluconazole penetration in female genital tissuesFan Wang, Olivie C Namuju, Katelyn A Pastick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsDavid B Meya, Yukari C Manabe, Barbara Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2016
Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in UgandaAgnes N Kiragga, Elizabeth Nalintya, Bozena M Morawski, et al.
Journal of Fungi (Basel, Switzerland)|February 26, 2026
False-Positive IMMY<sup>®</sup> Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration BufferAsmus Tukundane, Wilber Bakka, Mercy Amanige, et al.
Pageof 41

Showing results (181-190 of 409) with videos related to

Sort By:
Pageof 41
Wellcome Open Research|October 9, 2019
Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patientsRichard Kwizera, Fiona V Cresswell, Gerald Mugumya, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
BMC Infectious Diseases|June 28, 2019
Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort studyCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Diagnostic Microbiology and Infectious Disease|May 15, 2012
Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohortJosé E Vidal, Juliana Gerhardt, Erique J Peixoto de Miranda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2018
Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in TanzaniaDiana Faini, Aneth Vedastus Kalinjuma, Andrew Katende, et al.
Medical Mycology|May 15, 2020
Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agendaPeter G Pappas, David R Boulware, Dimitrios P Kontoyiannis, et al.
The Journal of Antimicrobial Chemotherapy|September 14, 2022
A post-mortem analysis of tenofovir, lamivudine, efavirenz and fluconazole penetration in female genital tissuesFan Wang, Olivie C Namuju, Katelyn A Pastick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2010
Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsDavid B Meya, Yukari C Manabe, Barbara Castelnuovo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2016
Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in UgandaAgnes N Kiragga, Elizabeth Nalintya, Bozena M Morawski, et al.
Journal of Fungi (Basel, Switzerland)|February 26, 2026
False-Positive IMMY<sup>®</sup> Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration BufferAsmus Tukundane, Wilber Bakka, Mercy Amanige, et al.
Pageof 41